1Ertenli I, Kirza S. Changes in the concentration and distribution of tissue factor pathway in hibitor in behcet, s disease and systemic lupus erythematosus, effect on the prethrombotic state[ J ]. Ann Rheum Disease, 2001,60 (5) : 1149-1151.
2Inoh M, Tokuda M, Kiuchi H, et al. Evaluation systemic lupus erythematosus disease Rheum [ J ]. 1996,39 (2) :287-289.
3Galle J. Atherosclerosis and arteriolitis: Implications for therapy of cardiovascular disease[ J]. Herz, 2004, 29( 1 ) : 4-11.
4Stenvinkel P. Inflammatory and atherosclerotic interactions in the depleted uremic patient [ J ]. Blood Purif,2001, 19 (5) :53-61.
